SEA
CLX icon

Stegent Equity Advisors’s Clorox CLX Stock Holding History

Stegent Equity Advisors’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,036
Closed -$991K – 118
2025
Q3 		$991K Buy
8,036
+2,698
+51% +$335K 0.81% 37
2025
Q2 		$641K Buy
5,338
+3,252
+156% +$434K 0.57% 52
2025
Q1 		$307K Sell
2,086
-445
-18% -$68K 0.31% 85
2024
Q4 		$411K Buy
2,531
+408
+19% +$66.7K 0.42% 60
2024
Q3 		$346K Buy
2,123
+487
+30% +$72.2K 0.38% 62
2024
Q2 		$223K Sell
1,636
-346
-17% -$48K 0.23% 76
2024
Q1 		$303K Buy
+1,982
New +$296K 0.31% 67

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Stegent Equity Advisors's CLX Position: Q4 2025 in Review

Stegent Equity Advisors sold out of Clorox (CLX) in Q4 2025, closing a stake of 8,036 shares — an estimated $991K sold.

Stegent Equity Advisors first reported a position in CLX in Q1 2024 and held it in 7 quarters. The position peaked at $991K in Q3 2025. 1,052 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Stegent Equity Advisors reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Stegent Equity Advisors sold 8,036 Clorox shares in Q4 2025, an estimated $991K.
  • Stegent Equity Advisors first reported a position in Clorox in Q1 2024 and held it in 7 quarters.
  • Stegent Equity Advisors's Clorox position peaked at $991K in Q3 2025.
  • 1,052 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Stegent Equity Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.